Shingles Clinical Trials 2024

Shingles Clinical Trials 2024

Shingles research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in shingles clinical trials today.

Popular filter options for shingles trials

Shingles Clinical Trials With No Placebo

View 16 shingles medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to shingles

What are the top hospitals conducting shingles research?

When it comes to clinical trials focused on shingles, several hospitals are making strides in research and treatment. Proactive Clinical Research, LLC in Fort Lauderdale is one such institution actively conducting a trial for this condition. While they do not yet have any completed shingles trials to their name, their dedication to finding solutions for patients with shingles is evident. In Honolulu, the East-West Medical Research Institute is also contributing to advancing knowledge about shingles through an ongoing clinical trial. With no previous trials conducted in this area either, their efforts show promise for future breakthroughs.

Centennial Medical Group located in Elkridge has joined the ranks of hospitals focusing on tackling the challenges of shingles through active clinical research as well. Like its counterparts mentioned above, Centennial Medical Group does not possess any prior experience with conducting shingles trials; however, their commitment signifies a continued effort within the medical community to explore new avenues of treatment and prevention.

Associates in Cardiology PA located in Silver Spring have similarly made strides by initiating an active clinical trial centered around shingles. As pioneers exploring this field further still lacks substantial groundwork which can be seen from absence of earlier attempts conducted by them or others alike.Their progress serves as a testament that even individualized healthcare practices play crucial roles when it comes to addressing unmet needs and pushing medical boundaries.

Finally Norfolk's Meridian Clinical Research joins these esteemed institutions with its own ongoing study dedicated solely towards understanding and combating against Shingle impact on lives.One may observe that like other smaller-scale facilities mentioned here ,they too lack elaborate history involving collection past accomplishments but regardless signifies that every step taken forward counts having profound implications waiting just around corner

Through these collective efforts across diverse locations throughout the United States—from sunny Florida all the way to tropical Hawaii—researchers are striving tirelessly toward improving our understanding of this painful viral infection known as shingles. Their dedication brings hope for those affected by providing opportunities for innovative treatments and potentially leading to the development of effective preventive measures.

Which are the best cities for shingles clinical trials?

When it comes to shingles clinical trials, several cities show promise in advancing research and treatment options. New york, New York leads the way with 6 active trials focused on studying SSA: Group 11 and other potential interventions. Columbus, Ohio follows closely behind with 3 ongoing studies examining similar treatments. Additionally, Stamford, Connecticut, Meridian, Idaho, and Rochester, New York each have 2 active trials investigating SSA: Group 11 and related approaches. These cities offer individuals affected by shingles access to cutting-edge clinical trials that may pave the path towards improved care and outcomes for this condition.

Which are the top treatments for shingles being explored in clinical trials?

When it comes to finding effective treatments for shingles, clinical trials have identified several promising options. Leading the pack is a drug known as Acyclovir, which has shown positive results in multiple studies. Another potential treatment being explored is Famciclovir, demonstrating its efficacy and safety profile in ongoing trials. Additionally, researchers are investigating the use of Valacyclovir as a potential therapy for shingles with encouraging outcomes thus far. These innovative treatments offer hope for individuals affected by this painful condition and may pave the way for improved management strategies in the future.

What are the most recent clinical trials for shingles?

Exciting progress is being made in the field of shingles research, with recent clinical trials offering new hope for those affected by this painful condition. One notable trial is SSA: Group 11, which has progressed to Phase 2 after an encouraging Phase 1. This study explores potential treatment options and their effectiveness against shingles. Additionally, another Phase 2 trial holds promise in evaluating a novel approach to combating shingles. With ongoing advancements in research and development, individuals suffering from this condition can anticipate improved outcomes and relief from the symptoms associated with shingles.

What shingles clinical trials were recently completed?

Recently completed clinical trials have made significant strides in the field of shingles research. Notably, a trial investigating a new vaccine candidate, sponsored by GlaxoSmithKline, concluded in June 2021. Another noteworthy completion was a trial exploring the efficacy of an antiviral medication called famciclovir, conducted by Novartis Pharmaceuticals and finalized in March 2021. These recent advancements highlight ongoing efforts to enhance prevention and treatment options for individuals affected by shingles and offer hope for better management of this painful condition.